Aimin Li Selected Research

Hepatocellular Carcinoma (Hepatoma)

11/2022	CXCR4-guided liposomes regulating hypoxic and immunosuppressive microenvironment for sorafenib-resistant tumor treatment.
1/2022	ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/MYH9/USP7/c-Myc axis.
1/2022	Comparative Toxicity Analyses from Different Endpoints: Are New Cyclic Disinfection Byproducts (DBPs) More Toxic than Common Aliphatic DBPs?
1/2022	PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells.
9/2021	EFNA4 promotes cell proliferation and tumor metastasis in hepatocellular carcinoma through a PIK3R2/GSK3β/β-catenin positive feedback loop.
1/2021	LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma.
10/2020	LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
1/2020	Anion-exchange resin adsorption followed by electrolysis: A new disinfection approach to control halogenated disinfection byproducts in drinking water.
1/2020	Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation.
11/2019	Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aimin Li Research Topics

Disease

54	Neoplasms (Cancer) 11/2022 - 03/2009
19	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 01/2014
18	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2015
17	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 08/2014
7	Glioma (Gliomas) 01/2022 - 08/2015
7	Stomach Neoplasms (Stomach Cancer) 09/2021 - 01/2017
7	Infections 06/2021 - 01/2007
6	Carcinogenesis 12/2021 - 07/2011
4	Disease Progression 12/2022 - 01/2016
4	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 01/2015
4	Hemorrhage 01/2021 - 01/2015
4	Carcinoma (Carcinomatosis) 07/2020 - 03/2009
4	Retinoblastoma (Glioblastoma, Retinal) 03/2003 - 05/2002
3	COVID-19 12/2022 - 01/2021
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 05/2022 - 01/2021
3	Fibrosis (Cirrhosis) 01/2022 - 07/2008
3	Nasopharyngeal Carcinoma 01/2022 - 05/2013
3	Body Weight (Weight, Body) 07/2020 - 01/2020
3	Atrophy 06/2020 - 07/2005
3	Human Influenza (Influenza) 01/2018 - 11/2013
3	Metrorrhagia (Spotting) 07/2007 - 07/2005
2	Hypoxia (Hypoxemia) 11/2022 - 01/2022
2	Pneumonia (Pneumonitis) 01/2022 - 05/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2014
2	Insulin Resistance 06/2021 - 01/2020
2	Lymphatic Metastasis 04/2021 - 01/2019
2	Brain Ischemia (Cerebral Ischemia) 01/2021 - 09/2020
2	Ischemic Stroke 01/2021 - 07/2019
2	Hypertension (High Blood Pressure) 09/2020 - 07/2019
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2020 - 01/2011
2	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019 - 10/2017
2	Alcoholism (Alcohol Abuse) 07/2019 - 01/2016
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2019 - 01/2015
2	Amyloid Plaque 01/2018 - 02/2008
2	Huntington Disease (Huntington's Disease) 01/2018 - 03/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 02/2008
2	Adenocarcinoma of Lung 10/2017 - 11/2014
2	Glucose Intolerance 10/2017 - 12/2013

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 07/2022 - 10/2002
13	Biomarkers (Surrogate Marker)IBA 07/2022 - 07/2011
10	MicroRNAs (MicroRNA)IBA 09/2021 - 08/2015
9	Messenger RNA (mRNA)IBA 01/2022 - 12/2011
8	Long Noncoding RNAIBA 01/2022 - 01/2019
7	CateninsIBA 01/2022 - 01/2013
7	Biological ProductsIBA 01/2021 - 01/2019
7	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2015
6	CytokinesIBA 01/2021 - 02/2005
4	Pharmaceutical PreparationsIBA 01/2022 - 11/2002
4	Capsules (Microcapsules)IBA 01/2019 - 08/2017
4	Therapeutic UsesIBA 01/2019 - 01/2014
4	Mifepristone (RU 486)FDA Link 07/2007 - 07/2005
3	Sorafenib (BAY 43-9006)FDA Link 11/2022 - 01/2014
3	InflammasomesIBA 07/2022 - 01/2020
3	AlbuminsIBA 05/2022 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2020
3	Carcinoembryonic AntigenIBA 04/2021 - 05/2016
3	HomocysteineIBA 09/2020 - 01/2019
3	Carrier Proteins (Binding Protein)IBA 07/2020 - 05/2016
3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 10/2016
3	beta CateninIBA 06/2013 - 03/2009
3	Contraceptive Agents (Contraceptives)IBA 03/2006 - 02/2005
3	ArrestinIBA 03/2003 - 05/2002
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2003 - 05/2002
2	Liposomes (Liposome)IBA 11/2022 - 12/2021
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2002
2	discoidin-binding polysaccharideIBA 01/2022 - 01/2020
2	ProdrugsIBA 01/2022 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2016
2	phenazine FDA Link 01/2022 - 01/2016
2	Docetaxel (Taxotere)FDA Link 12/2021 - 10/2017
2	IntegrinsIBA 12/2021 - 10/2018
2	AntibodiesIBA 10/2021 - 01/2014
2	LipidsIBA 06/2021 - 01/2019
2	Insulin (Novolin)FDA Link 06/2021 - 01/2020
2	CarbohydratesIBA 04/2021 - 01/2020
2	CollagenIBA 04/2021 - 09/2009
2	AntigensIBA 04/2021 - 01/2020
2	HydrogelsIBA 01/2021 - 06/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2019
2	Small Nucleolar RNA (snoRNA)IBA 10/2020 - 01/2020
2	ElementsIBA 07/2020 - 05/2002
2	Transforming Growth Factor beta (TGF-beta)IBA 07/2020 - 03/2009
2	Bleomycin (Blenoxane)FDA LinkGeneric 07/2020 - 01/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2020 - 06/2020
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 10/2015
2	Temozolomide (Temodar)FDA LinkGeneric 07/2019 - 08/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 05/2016
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2016
2	polyglutamineIBA 01/2018 - 03/2013
2	Apolipoproteins E (ApoE)IBA 01/2018 - 02/2008
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 02/2008
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018 - 10/2017
2	N 30IBA 01/2018 - 09/2009

Therapy/Procedure

13	Therapeutics 12/2022 - 07/2010
5	Drug Therapy (Chemotherapy) 01/2020 - 08/2015
2	Splenectomy 01/2018 - 01/2015
2	Long-Term Care 01/2018 - 11/2013